newsfilter
← Latest News
GlobeNewswire·

REMINDER: ImmunityBio, Inc. Investors With Significant Losses Must Act By May 26, 2026

NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds ImmunityBio, Inc. ("ImmunityBio" or the "Company") (NASDAQ:IBRX) investors of the May 26, 2026 deadline to seek the role of lead plaintiff in a